Bone turnover markers (BTMs) are used widely, in both research and clinical practice. In the
last 20 years, much experience has been gained in measurement and interpretation of these …

Context Androgen-deprivation therapy (ADT) is a key component of treatment for aggressive
and advanced prostate cancer, but it has also been associated with adverse effects on bone …

Beside cytotoxic drugs, other drugs can impact men's fertility through various mechanisms.
Via the modification of the hypothalamic–pituitary–gonadal axis hormones or by non …

Purpose Androgen suppression therapy (AST) results in musculoskeletal toxicity that
reduces physical function and quality of life. This study examined the impact of a combined …

Context: The cause of declining testosterone (T) in aging men and their relationships with
risk factors are unclear. Objective: The objective of the study was to investigate the …

Cardiovascular disease and cancer are the leading causes of death in the United States,
and hormone-dependent cancers (breast and prostate cancer) are the most common …

Loss of estrogens or androgens increases the rate of bone remodeling by removing
restraining effects on osteoblastogenesis and osteoclastogenesis, and also causes a focal …

Purpose Prostate cancer (PCa) is one of the most common cancers in men. Men with
recurrent or metastatic PCa are treated with androgen-deprivation therapy (ADT), resulting …

Research conducted in the last fifteen years has placed in question many of the traditional
conclusions scholars have formed about human female sexuality. Though conventional …

Introduction There are many data on sexual problems subsequent to cancer and its
treatment, although the likelihood of problems in specific individuals depends on multiple …